Antidepressant Manufacturer Trial Information Requested By Senate Cmte.
Executive Summary
Antidepressant manufacturers have until Aug. 27 to submit information about pediatric clinical trials to the Senate Finance Committee
You may also be interested in...
Merck Clarifies ClinicalTrials.gov Postings; Listed As Sponsor Of 13 Studies
Merck is enrolling patients in three type 2 diabetes trials - including pioglitazone and metformin add-on studies - for a late-stage investigational drug, according to the company's recently updated postings on the HHS-sponsored website ClinicalTrials.gov
FDA Drug Safety Office Is “Separate, But Unequal,” Senate Committee Says
A Senate committee investigation into FDA's handling of pediatric suicidality concerns with antidepressant drugs is focusing on the "unequal" status of the Office of Drug Safety and the Office of New Drugs
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011